Figure 4 — Decitabine in combination with low-dose cytarabine, aclarubicin and G-CSF tends to improve prognosis in elderly patients with high-risk AML

Research Paper|Volume 12, Issue 7|pp. 5792–5811

Decitabine in combination with low-dose cytarabine, aclarubicin and G-CSF tends to improve prognosis in elderly patients with high-risk AML

Back to articleFigure 4(4 of 8)

100%

Figure 4.Overall survival and disease free survival according to risk groups (low-risk vs intermediate-risk vs high-risk). (A) Overall survival in low-, intermediate- and high-risk patients. (B) Disease free survival in low-, intermediate- and high-risk patients.